Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sol Schulman, M.D., Ph.D.

Concepts (154)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sol Schulman's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sol Schulman has written about over time.
Mixed Function Oxygenases, 2 publications between 2010 and 2010, average publication date May 2010. Thioredoxins, 1 publications between 2010 and 2010, average publication date August 2010. Anemia, Hemolytic, Autoimmune, 1 publications between 2012 and 2012, average publication date August 2012. Blood Coagulation Disorders, 1 publications between 2014 and 2014, average publication date November 2014. Rodenticides, 1 publications between 2014 and 2014, average publication date November 2014. Vitamin K, 1 publications between 2014 and 2014, average publication date November 2014. Endoplasmic Reticulum, 3 publications between 2010 and 2024, average publication date June 2015. Hemorrhage, 3 publications between 2014 and 2016, average publication date October 2015. Protein Disulfide-Isomerases, 3 publications between 2011 and 2024, average publication date March 2017. Thrombosis, 4 publications between 2015 and 2023, average publication date June 2018. Polymorphism, Single Nucleotide, 3 publications between 2016 and 2023, average publication date August 2018. von Willebrand Diseases, 2 publications between 2017 and 2023, average publication date May 2020. Blood Coagulation Disorders, Inherited, 1 publications between 2020 and 2020, average publication date September 2020. Frameshift Mutation, 1 publications between 2020 and 2020, average publication date September 2020. Factor VIIa, 1 publications between 2021 and 2021, average publication date January 2021. Blood Platelets, 3 publications between 2016 and 2024, average publication date May 2021. Thromboplastin, 4 publications between 2020 and 2023, average publication date March 2022. Hemophilia A, 1 publications between 2023 and 2023, average publication date September 2023. Hemostatics, 1 publications between 2023 and 2023, average publication date September 2023. von Willebrand Disease, Type 2, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Schulman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (154)
Explore
_
Co-Authors (31)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.